Quest for a Cure

Help us chase our cure at this year’s

virtual Quest for a Cure Benefit

Thursday, November 12, 2020

The Castleman Disease Collaborative Network (CDCN) invites you to the 6th annual Quest for a Cure Benefit! This years virtual benefit has the potential to join together our largest group of patients, loved ones, and community members to raise awareness and funds for life-saving Castleman disease research. The CDCN’s co-founder, Dr. David Fajgenbaum, physician-scientist at the University of Pennsylvania and author of Chasing My Cure: A Doctor’s Race to Turn Hope Into Action, is this year’s keynote speaker. To purchase tickets and become a sponsor click here

Event Details

Quest for a Cure will be held virtually this year
Thursday, November 12, 2020, 8pm EST
Interested in being a part of the event committee: Email us
More Details to follow!

Sponsorships & Tickets

All sponsorships will be recognized on our website for one year.

The CDCN is a 501 (c) (3) nonprofit organization. All donations are tax deductible in accordance with IRS regulations.

Crusader Sponsor $25,000

Recognition in all materials publicizing the event
Purchase your sponsorship here.

Castleman Sponsor $10,000

Recognition in all materials publicizing the event
Purchase your sponsorship here.

King Sponsor $5,000

Recognition in all materials publicizing the event
Purchase your sponsorship here.

Knight Sponsor $2,500

Recognition in all materials publicizing the event
Purchase your sponsorship here.

Bishop Sponsor $1,250

Recognition in all materials publicizing the event
Purchase your sponsorship here.

Noble Sponsor $500

Recognition on event signage
Purchase your sponsorship here.

Warrior Individual Registration

Thank you to all our sponsors who helped make our 2019 Quest for a Cure our best year yet! We could not have done this without you!

About the CDCN

The CDCN’s innovative approach to transform Castleman disease research over the last seven years has resulted in the first diagnostic criteria for Castleman disease, first treatment guidelines, first new drug target in 25 years, and first clinical trial for patients with treatment-refractory Castleman disease. This work has been profiled on Good Morning America, New York Times, CNN, Philadelphia Inquirer, NPR Fresh Air, and the Lifetime TV Network. The CDCN has also partnered with the Chan Zuckerberg Initiative to expand the CDCN’s approach to research to advance cures for other rare diseases.

More Information

Prefer to send a check by mail? Make out to: “CDCN” (Castleman Disease Collaborative Network), notate ‘Quest for A Cure,’ and send to: Castleman Disease Collaborative Network, PO Box 3614 Paso Robles, CA 93447
Questions? Email quest@castlemannetwork.org or call (610) 304-0696
CDCN is a 501 (c) (3) nonprofit organization. All donations are tax deductible in accordance with IRS regulations.